Skip to content
Polis

House bill · 89R

HB 3785

Relating to labeling requirements for compounded drug products.

Did not pass

Progress

54 days from first to latest action, across 9 recorded actions.

  1. Filed

    Mar 5

  2. Referred to committee

    Mar 26

  3. Heard in committee

    Apr 14

  4. Reported from committee

    Stopped here

  5. Passed first chamber

  6. Passed second chamber

  7. Sent to governor

  8. Became law

HouseApr

Filled marks are milestones (committee report, floor passage, governor action). Larger marks hold more same-day actions.

Full history

Every action recorded by Texas Legislature Online.

  1. Failed to receive affirmative vote in comm. Public Health

    Apr 28, 2025 · House

  2. Committee substitute considered in committee

    Apr 28, 2025 · House

  3. Considered in public hearing Public Health

    Apr 28, 2025 · House

  4. Left pending in committee

    Apr 14, 2025 · House

  5. Testimony taken/registration(s) recorded in committee Public Health

    Apr 14, 2025 · House

  6. Considered in public hearing Public Health

    Apr 14, 2025 · House

  7. Referred to Public Health Public Health

    Mar 26, 2025 · House

  8. Read first time

    Mar 26, 2025 · House

  9. Filed

    Mar 5, 2025 · House

Authors

In committee

  • Public Health

    House

    Referred Mar 26, 2025 · heard Apr 14, 2025 · failed in committee

Topics

Bill text

Bills on similar topics

Other legislation this session sharing the most index topics.

HB 3785 (89R) · Polis